UROTHELIAL CARCINOMA (UC)

This study is testing a two-part approach for people with advanced cancers that cannot be removed by surgery. First, a special imaging scan is used to see if a tumor has a specific target. If it does, a targeted radiation treatment is given to try to control the cancer. The main …

This early-stage study is testing a new drug, IDE892, both alone and in combination with another drug called IDE397. It is for adults with advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main g…

This study is testing a new drug called XL092, both by itself and in combination with other immunotherapy drugs, for people with advanced solid tumors that cannot be removed by surgery. The main goals are to find safe doses and see if the treatments can shrink tumors or slow thei…

This study is testing a new type of test, called a liquid biopsy, that uses blood and urine samples to help with bladder cancer. The goal is to see if this test can help doctors diagnose the cancer, see how well treatment is working, and spot if the cancer comes back. Researchers…

This study aims to collect detailed information from 300 Korean patients with aggressive upper tract bladder cancer who receive chemotherapy and surgery. Researchers will track patients for up to five years, collecting blood samples and health data to understand how and when canc…